Oxford Biomedica PLC/ GB00BDFBVT43 /
| 2024-05-29 7:57:19 AM | Chg. -0.1400 | Volume | Bid12:38:07 PM | Ask12:38:07 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3.7600EUR | -3.59% | - Turnover: - |
3.7400Bid Size: 2,700 | 3.8000Ask Size: 2,700 | 302.73 mill.EUR | - | - |
Assets
| 2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 8.9000 | 24.4000 | 27.5000 | 25.4000 | 31.8000 | ||||||
| Intangible Assets | 2.1000 | 1.7000 | 1.3000 | .1000 | .1000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 1.4000 | 2.7000 | 2.2000 | 3.3000 | 4.3000 | ||||||
| Accounts Receivable | 3.6000 | 7.4000 | 2 | 5.7000 | 15.4000 | ||||||
| Cash and Cash Equivalents | 14.2000 | 9.4000 | 15.3000 | 14.3000 | 32.2000 | ||||||
| Current Assets | 22.8000 | 25.7000 | 27.4000 | 37 | 69.5000 | ||||||
| Total Assets | 33.9000 | 51.9000 | 56.9000 | 65.4000 | 112.4000 | ||||||
Liabilities
| 2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.8000 | 3.6000 | 1.6000 | 8.7000 | 11.4000 | ||||||
| Long-term debt | 1 | 27.3000 | 34.4000 | 36.9000 | 41.2000 | ||||||
| Liabilities to Banks | 1 | 27.3000 | 34.4000 | 36.9000 | 41.2000 | ||||||
| Provisions | .5000 | 1.3000 | .6000 | .6000 | 1.6000 | ||||||
| Liabilities | 10.8000 | 41 | 44.3000 | 59.3000 | 77.7000 | ||||||
| Share Capital | 25.6590 | 25.7410 | 30.8790 | 31.0760 | 33.0340 | ||||||
| Total Equity | 23 | 10.9000 | 12.6000 | 6.1000 | 34.7000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 33.9000 | 51.9000 | 56.9000 | 65.4000 | 112.4000 | ||||||
Income Statement
| 2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 13.6000 | 15.9000 | 27.8000 | 37.6000 | 66.8000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -10.6000 | -14.1000 | -11.3000 | -5.7000 | 13.9000 | ||||||
| Interest Income | -.1500 | -2.8700 | -8.9700 | -6.0600 | -8.9300 | ||||||
| Income Before Taxes | -10.8000 | -17 | -20.3000 | -11.8000 | 5 | ||||||
| Income Taxes | -2.1000 | -4 | -3.7000 | -2.7000 | -2.5000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -8.7000 | -13 | -16.6000 | -9 | 7.5000 | ||||||
Per Share
Cash Flow
| 2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -6 | -13.1000 | -5.1000 | 3 | 12.9000 | ||||||
| Cash Flow from Investing Activities | -5.5000 | -16.7000 | -6.4000 | -1.9000 | -10.1000 | ||||||
| Cash Flow from Financing | 23.6000 | 25 | 17.5000 | -2.1000 | 15.1000 | ||||||
| Decrease / Increase in Cash | 12 | -4.8000 | 6 | -1 | 17.9000 | ||||||
| Employees | 134 | 231 | 256 | 321 | 432 | ||||||
